Entering text into the input field will update the search result below

Amgen (NASDAQ:AMGN): Q2 EPS of $1.29 beats by $0.13. Revenue of $3.7B (-1%) vs. $3.6B. Raises...

Jul. 27, 2009 4:07 PM ETAmgen Inc. (AMGN)AMGNBy: Jason Aycock, SA News Editor2 Comments
Amgen (NASDAQ:AMGN): Q2 EPS of $1.29 beats by $0.13. Revenue of $3.7B (-1%) vs. $3.6B. Raises full-year EPS guidance to $4.80-4.95 vs. $4.57. Shares +2.5% AH. (PR)

Recommended For You

Comments (2)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Vieira Trading profile picture
Beyond Trading on (AMGN) "great companies are like great investors; you can get it wrong once or twice but the substance is there long term"
Vieira Trading profile picture
we're still holding to our recommendation from $52 long on this one; this is good money in you pocket long term
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.